Assessment of treatment outcomes of HIV-positive adolescents on a dolutegravir- based regimen at a specialized paediatric HIV clinic in Lesotho

dc.contributor.advisor	van Wyk, Brian
dc.contributor.author	Letsika, Motlatsi
dc.date.accessioned	2023-08-04T07:55:38Z
dc.date.available	2023-08-04T07:55:38Z
dc.date.issued	2023
dc.identifier.uri	http://hdl.handle.net/11394/10441
dc.description	Magister Artium - MA	en_US
dc.description.abstract	Background: Globally, adolescents on antiretroviral therapy (ART) have comparatively worse treatment outcomes (i.e., low viral load suppression rates) compared to adults and children. Lesotho introduced Dolutegravir (DTG), to replace Efavirenz, as a more potent first line and second-line drug regimen for ART in 2018. However, no study has been conducted to date to assess the effectiveness of this change in regimen on treatment outcomes of adolescents on ART in Lesotho.	en_US
dc.language.iso	en	en_US
dc.publisher	University of the Western Cape	en_US
dc.subject	Viral load	en_US
dc.subject	Suppression	en_US
dc.subject	Dolutegravir	en_US
dc.subject	HIV Treatment	en_US
dc.subject	Adolescents	en_US
dc.title	Assessment of treatment outcomes of HIV-positive adolescents on a dolutegravir- based regimen at a specialized paediatric HIV clinic in Lesotho	en_US
dc.rights.holder	University of the Western Cape	en_US